Liver Biology/Pathobiology

You have full text access to this OnlineOpen article

An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-ᆇ

  1. Benjamin D. Cosgrove1,3,4,
  2. Connie Cheng5,
  3. Justin R. Pritchard2,3,
  4. Donna B. Stolz6,
  5. Douglas A. Lauffenburger1,2,3,4,
  6. Linda G. Griffith1,4,§,*

Article first published online: 24 MAR 2008

DOI: 10.1002/hep.22335

Issue

Hepatology

Hepatology

Volume 48, Issue 1, pages 276–288, July 2008

Additional Information

How to Cite

Cosgrove, B. D., Cheng, C., Pritchard, J. R., Stolz, D. B., Lauffenburger, D. A. and Griffith, L. G. (2008), An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-α. Hepatology, 48: 276–288. doi: 10.1002/hep.22335

Author Information

  1. 1

    Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA

  2. 2

    Department of Biology, Massachusetts Institute of Technology, Cambridge, MA

  3. 3

    Department of Cell Decision Processes Center, Massachusetts Institute of Technology, Cambridge, MA

  4. 4

    Department of Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge, MA

  5. 5

    School of Engineering and Applied Sciences, Harvard University, Cambridge, MA

  6. 6

    Departments of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, PA

  1. §

    fax: 617-253-2400.

*Dept. of Biological Engineering, M.I.T., Room 16-429, 77 Massachusetts Avenue, Cambridge, MA 02139

  1. †

    Animal Experimentation Statement: All animals received humane care according to the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National Academy of Sciences and published by the NIH (NIH publication 86–23).

  2. ‡

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 20 JUN 2008
  2. Article first published online: 24 MAR 2008
  3. Accepted manuscript online: 24 MAR 2008 12:00AM EST
  4. Manuscript Accepted: 11 MAR 2008
  5. Manuscript Received: 19 OCT 2007

Funded by

  • National Institutes of Health (NIH). Grant Number: P50-GM68762
  • DoD Institute for Collaborative Biotechnologies
  • Massachusetts Institute of Technology (MIT) Biotechnology Process Engineering Center
  • MIT Center for Environmental Health Sciences. Grant Numbers: NIH U19ES011399, NIH CA76541
  • Whitaker Foundation Graduate Fellowship

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (2176K)

References

  • 1
    Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583–G589.
  • 2
    Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006; 124: 1225–1239.
  • 3
    Miller-Jensen K, Janes KA, Wong YL, Griffith LG, Lauffenburger DA. Adenoviral vector saturates Akt pro-survival signaling and blocks insulin-mediated rescue of tumor necrosis-factor-induced apoptosis. J Cell Sci 2006; 119: 3788–3798.
  • 4
    Plumpe J, Streetz K, Manns MP, Trautwein C. Tumour necrosis factor alpha—mediator of apoptosis and cell proliferation of hepatocytes. Ital J Gastroenterol Hepatol 1999; 31: 235–243.
  • 5
    Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836–847.
  • 6
    Diehl AM, Yin M, Fleckenstein J, Yang SQ, Lin HZ, Brenner DA, et al. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol 1994; 267: G552–G561.
  • 7
    Webber EM, Bruix J, Pierce RH, Fausto N. Tumor necrosis factor primes hepatocytes for DNA replication in the rat. HEPATOLOGY 1998; 28: 1226–1234.
    Direct Link:
  • 8
    Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Santamaria M, Lee DC, et al. Novel role for amphiregulin in protection from liver injury. J Biol Chem 2005; 280: 19012–19020.
  • 9
    Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A 1989; 86: 1558–1562.
  • 10
    Iocca HA, Isom HC. Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am J Pathol 2003; 163: 465–476.
  • 11
    Argast GM, Campbell JS, Brooling JT, Fausto N. Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J Biol Chem 2004; 279: 34530–34536.
  • 12
    Gallucci RM, Simeonova PP, Toriumi W, Luster MI. TNF-alpha regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. J Immunol 2000; 164: 872–878.
  • 13
    Boulton R, Woodman A, Calnan D, Selden C, Tam F, Hodgson H. Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. HEPATOLOGY 1997; 26: 49–58.
  • 14
    Wang Z, Wang M, Carr BI. The inhibitory effect of interleukin 1beta on rat hepatocyte DNA synthesis is mediated by nitric oxide. HEPATOLOGY 1998; 28: 430–435.
    Direct Link:
  • 15
    Wang WH, Gregori G, Hullinger RL, Andrisani OM. Sustained activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase pathways by hepatitis B virus X protein mediates apoptosis via induction of Fas/FasL and tumor necrosis factor (TNF) receptor 1/TNF-alpha expression. Mol Cell Biol 2004; 24: 10352–10365.
  • 16
    Shayakhmetov DM, Li ZY, Ni S, Lieber A. Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors. J Immunol 2005; 174: 7310–7319.
  • 17
    Del Castillo G, Murillo MM, Alvarez-Barrientos A, Bertran E, Fernandez M, Sanchez A, et al. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Exp Cell Res 2006; 312: 2860–2871.
  • 18
    Fujioka N, Mukaida N, Harada A, Akiyama M, Kasahara T, Kuno K, et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J Leukoc Biol 1995; 58: 90–98.
  • 19
    Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice. Mol Carcinog 1996; 15: 183–189.
    Direct Link:
  • 20
    Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005; 310: 1646–1653.
  • 21
    Gabay C, Porter B, Guenette D, Billir B, Arend WP. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999; 93: 1299–1307.
  • 22
    Tsukui T, Kikuchi K, Mabuchi A, Sudo T, Sakamoto T, Asano G, et al. Production of interleukin-1 by primary cultured parenchymal liver cells (hepatocytes). Exp Cell Res 1994; 210: 172–176.
  • 23
    Hwa AJ, Fry RC, Sivaraman A, So PT, Samson LD, Stolz DB, Griffith LG. Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J 2007; 21: 2564–2579.
  • 24
    Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996; 132: 1133–1149.
  • 25
    Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323–340.
  • 26
    Chaisson ML, Brooling JT, Ladiges W, Tsai S, Fausto N. Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest 2002; 110: 193–202.
  • 27
    Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, et al. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J 2008; 27: 212–223.
  • 28
    Serandour AL, Loyer P, Garnier D, Courselaud B, Theret N, Glaise D, et al. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. HEPATOLOGY 2005; 41: 478–486.
    Direct Link:
  • 29
    Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA. Common effector processing mediates cell-specific responses to stimuli. Nature 2007; 448: 604–608.
  • 30
    Zhang F, Cheng J, Hackett NR, Lam G, Shido K, Pergolizzi R, et al. Adenovirus E4 gene promotes selective endothelial cell survival and angiogenesis via activation of the vascular endothelial-cadherin/Akt signaling pathway. J Biol Chem 2004; 279: 11760–11766.
  • 31
    Burns K, Martinon F, Tschopp J. New insights into the mechanism of IL-1beta maturation. Curr Opin Immunol 2003; 15: 26–30.
  • 32
    Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997; 8: 253–265.
  • 33
    Kim JE, Tannenbaum SR. S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells. J Biol Chem 2004; 279: 9758–9764.
  • 34
    Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A, et al. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 2005; 26: 2086–2094.
  • 35
    Monine MI, Berezhkovskii AM, Joslin EJ, Wiley HS, Lauffenburger DA, Shvartsman SY. Ligand accumulation in autocrine cell cultures. Biophys J 2005; 88: 2384–2390.
  • 36
    Tschumperlin DJ, Dai G, Maly IV, Kikuchi T, Laiho LH, McVittie AK, et al. Mechanotransduction through growth-factor shedding into the extracellular space. Nature 2004; 429: 83–86.
  • 37
    Scheving LA, Zhang L, Stevenson MC, Kwak ES, Russell WE. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling. Am J Physiol Gastrointest Liver Physiol 2006; 291: G16–G25.
  • 38
    Kiso S, Kawata S, Tamura S, Miyagawa J, Ito N, Tsushima H, et al. Expression of heparin-binding epidermal growth factor-like growth factor in the hepatocytes of fibrotic rat liver during hepatocarcinogenesis. J Gastroenterol Hepatol 1999; 14: 1203–1209.
    Direct Link:
  • 39
    Castillo J, Erroba E, Perugorria MJ, Santamaria M, Lee DC, Prieto J, et al. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res 2006; 66: 6129–6138.
  • 40
    Stelling J, Sauer U, Szallasi Z, Doyle FJ 3rd, Doyle J. Robustness of cellular functions. Cell 2004; 118: 675–685.
  • 41
    Webber EM, Wu JC, Wang L, Merlino G, Fausto N. Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994; 145: 398–408.
View Full Article with Supporting Information (HTML) Get PDF (2176K)